Chromogranin A (CgA) Level

Original price was: ₹3,200.00.Current price is: ₹1,999.00.

Chromogranin A (CgA) Level Test

The Chromogranin A (CgA) test measures the level of CgA protein in the blood, which is a biomarker for neuroendocrine tumors (NETs). It helps in diagnosing, monitoring, and assessing treatment response for NETs, including carcinoid tumors, pheochromocytomas, pancreatic NETs, and neuroblastomas.


Why is the Chromogranin A Test Done?

🔹 To diagnose neuroendocrine tumors (NETs) – Carcinoid tumors, pheochromocytomas, pancreatic NETs
🔹 To monitor tumor progression or treatment response – Especially for patients already diagnosed with NETs
🔹 To differentiate NETs from other conditions – Helps distinguish from other causes of symptoms like flushing, diarrhea, or high blood pressure


Normal Range for Chromogranin A (CgA)

  • Typical range: <100 ng/mL (varies by laboratory)

  • Elevated levels may indicate a neuroendocrine tumor or other conditions


Interpreting the Results

CgA Level Possible Causes
Mildly Elevated – Chronic gastritis (H. pylori infection)
Proton pump inhibitors (PPIs) (e.g., Omeprazole, Pantoprazole)
– Chronic kidney or liver disease
Moderately to Highly Elevated Neuroendocrine Tumors (NETs) (Carcinoid tumors, Pheochromocytomas, Pancreatic NETs)
Neuroblastoma
Medullary Thyroid Carcinoma (MTC)
Adrenal Gland Tumors (Pheochromocytoma)

Factors That Can Affect Chromogranin A Levels

🚫 Proton Pump Inhibitors (PPIs) – Can falsely elevate CgA (stop 1-2 weeks before testing)
💊 Chronic Kidney Disease (CKD) – Can cause mild to moderate elevation
🍽 Recent Meals – Fasting before the test is recommended for accurate results


Additional Tests for NET Diagnosis

🔹 24-hour Urine 5-HIAA (5-Hydroxyindoleacetic Acid) – Detects serotonin breakdown (for carcinoid tumors)
🔹 Metanephrines & Catecholamines (Plasma or Urine) – To diagnose pheochromocytoma
🔹 Imaging Tests (CT, MRI, PET Scan with Ga-68 DOTATATE) – To locate NETs


Next Steps if CgA is Elevated

Repeat the test after stopping PPIs (if applicable)
Further NET-specific testing (e.g., 5-HIAA, imaging)
Consult an endocrinologist or oncologist for further evaluation